
Loading, please wait...

Loading, please wait...

Researchers at Spain's University of Granada have developed a fish scale artificial cornea. This innovative medical device utilizes scales from several common fish species found in local markets. Consequently, it provides a promising, lower-cost alternative to traditional donor transplants for patients with severe eye diseases.
The cornea is the eye's transparent front layer. However, it is remarkably difficult to repair when badly damaged because it lacks blood vessels and has limited regenerative capacity. Doctors often treat severe corneal conditions with donor transplants. Unfortunately, these procedures are frequently limited by organ availability and long waiting lists.
Scientists from the university's Tissue Engineering Group created these corneal implants to be highly biocompatible, transparent, and resistant. Furthermore, this biological product is very accessible and inexpensive to obtain. It could also help boost the local fishing industry by utilizing byproducts. Testing suggests the material is highly useful for corneal repair and tissue regeneration. Nevertheless, the technology remains far from clinical use in humans until human trials are complete.
The research team reported good functional results in both laboratory studies and animal models. Although standard transplants usually offer good results, we must develop new effective regeneration methods. These methods should not depend solely on organ donation. A 2016 peer-reviewed paper from Antwerp University also confirmed that fish-scale-derived corneas were compatible with human tissues. Therefore, this innovation marks a significant step forward in regenerative medicine.
Q1: Why are fish scales used for artificial corneas?
Fish scales are naturally transparent, durable, and highly biocompatible. They provide a cost-effective scaffold that mimics the protein structure of the human cornea.
Q2: When will this treatment be available for patients?
While laboratory and animal trials are successful, human clinical trials must be completed before the treatment is approved for general medical use.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Spanish researchers develop a low-cost artificial cornea from fish scales, offering a biocompatible alternative to donor transplants for severe eye diseases...
4 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today